Biotek-snakken — September 2023
-
Ny analyse: Dansk life science-industri har aldrig stået stærkere
Erhvervsministeriet offentliggør i dag en ny analyse for life science i Danmark, der viser industriens voksende betydning for dansk økonomi. Men der er også visse punkter med plads til forbedring.
-
Amerikansk biotekaktie saves midt over efter studieflop https://www.proinvestor.com/investornyt/1048504/amerikansk-biotekaktie-saves-midt-over-efter-studieflop
-
Ascelia Pharma når headline-resultat från SPARKLE-utläsningen i maj 2024 med nuvarande finansiering:
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind